International Flavors & Fragrances Inc. (IFF) has garnered the attention of asset management firms such as
Nomura, Wells Fargo and Assetmark, contributing to the firm's stock performance, even in the face of losses. This robustness has been bolstered by the welcoming of a new
Board Member and potentially surprising
earnings predictions. The firm's readiness to trim assets is evident with the recent
deal to sell its
Pharma Solutions business for $2.85 billion. Despite some financial entities downsizing their IFF stake, like Wells Fargo, PNC Financial Group and Principal Securities, other organizations like
Quadrant Capital and
Norges Bank continue to leverage their positions, suggesting mixed investor sentiment. IFF has also made noteworthy strides in product development, including offering
Vegan Supplements. However, recent
dividend cuts and weaker forecasts have influenced negative perceptions, and criticisms about IFF's debt layering add to concerns. Despite facing a slight revenue dip in Q1, IFF's institutional ownership remains high at
87%. The firm's price target forecasts have increased, but
risks to shareholder returns at current prices are high. Notwithstanding these challenges, the firm's new CEO,
J. Erik Fyrwald, could offer fresh strategic directions, and a recently launched
advertising campaign indicates IFF's ongoing market presence.
International Flavors Fragrances IFF News Analytics from Wed, 20 Sep 2023 07:00:00 GMT to Thu, 30 May 2024 21:52:59 GMT -
Rating -1
- Innovation 2
- Information 7
- Rumor 3
